Federal Grant to Fund Inhaled Vaccines
A $20.7M federal grant will fund a 5-year inhaled vaccines initiative at the Icahn School of Medicine at Mount Sinai beginning with development of an avian influenza nasal spray prototype.
A $20.7M federal grant will fund a 5-year inhaled vaccines initiative at the Icahn School of Medicine at Mount Sinai beginning with development of an avian influenza nasal spray prototype.
Study shows immune responses to flu and COVID-19 trigger lasting inflammation in the spine, hastening onset/progression of amyotrophic lateral sclerosis (ALS).
The federal agency restructured its flu and COVID-19 units into a unified Influenza and Respiratory Viruses Division (IRVD).
Less than 44% of people in the US received a flu shot during the 2025-2026 season, down from 52% in 2021.
The new multi-dose RSV vial is expected to lower costs and simplify global distribution to protect infants from severe respiratory illness.
A new international initiative aims to provide countries with equitable, rapid access to vaccines during mpox disease surges.